Annovis Bio (ANVS)
(Real Time Quote from BATS)
$7.55 USD
+0.70 (10.22%)
Updated May 14, 2024 11:54 AM ET
2-Buy of 5 2
D Value B Growth C Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ANVS 7.55 +0.70(10.22%)
Will ANVS be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for ANVS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ANVS
Novo Nordisk (NVO) Up 3% as Haemophilia Drug Meets Study Goals
Amicus (FOLD) Q1 Earnings Top, Sales Lag, '24 Outlook Updated
ANVS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Xenon (XENE) Q1 Earnings Beat Estimates, Pipeline in Focus
Catalyst (CPRX) Q1 Earnings Beat, Firdapse Sales Drive Revenues
Acadia (ACAD) Q1 Earnings Surpass Estimates, Revenues Miss
Other News for ANVS
ANVS Stock Earnings: Annovis Bio Beats EPS for Q1 2024
Stocks with more than 10% short interest - Finviz Screener
Largest borrow rate increases among liquid names
Annovis Bio Provides Corporate Updates and Announces First Quarter 2024 Financial Results
Annovis Bio GAAP EPS of -$0.10 beats by $0.53